{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:19:51Z","timestamp":1785813591080,"version":"3.56.0"},"reference-count":202,"publisher":"Bentham Science Publishers Ltd.","issue":"33","funder":[{"DOI":"10.13039\/100009392","name":"Prince Satam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2023\/R\/1444"],"award-info":[{"award-number":["PSAU\/2023\/R\/1444"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The immune system is the key player in a wide range of responses in normal tissues and tumors to\nanticancer therapy. Inflammatory and fibrotic responses in normal tissues are the main limitations\nof chemotherapy, radiotherapy, and also some newer anticancer drugs such as immune checkpoint\ninhibitors (ICIs). Immune system responses within solid tumors including anti-tumor and tumor-\npromoting responses can suppress or help tumor growth. Thus, modulation of immune cells\nand their secretions such as cytokines, growth factors and epigenetic modulators, pro-apoptosis\nmolecules, and some other molecules can be suggested to alleviate side effects in normal tissues\nand drug-resistance mechanisms in the tumor. Metformin as an anti-diabetes drug has shown intriguing\nproperties such as anti-inflammation, anti-fibrosis, and anticancer effects. Some investigations\nhave uncovered that metformin can ameliorate radiation\/chemotherapy toxicity in normal\ncells and tissues through the modulation of several targets in cells and tissues. These effects of metformin\nmay ameliorate severe inflammatory responses and fibrosis after exposure to ionizing radiation\nor following treatment with highly toxic chemotherapy drugs. Metformin can suppress the activity\nof immunosuppressive cells in the tumor through the phosphorylation of AMP-activated protein\nkinase (AMPK). In addition, metformin may stimulate antigen presentation and maturation of\nanticancer immune cells, which lead to the induction of anticancer immunity in the tumor. This review\naims to explain the detailed mechanisms of normal tissue sparing and tumor suppression during\ncancer therapy using adjuvant metformin with an emphasis on immune system responses.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230703143907","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T05:47:58Z","timestamp":1688536078000},"page":"5370-5396","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Metformin Immunoregulatory Actions in Tumor Suppression\nand Normal Tissues Protection"],"prefix":"10.2174","volume":"31","author":[{"given":"Jitendra","family":"Gupta","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Pin Code 281406, U. P., India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abduladheem Turki","family":"Jalil","sequence":"additional","affiliation":[{"name":"Medical Laboratories Techniques Department, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa Hamzaa","family":"Abd Alzahraa","sequence":"additional","affiliation":[{"name":"National University of Science and Technology, Dhi Qar, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar","family":"Aminov","sequence":"additional","affiliation":[{"name":"Department of Public Health and Healthcare management, Samarkand State Medical University, 18 Amir Temur Street, Samarkand, Uzbekistan"},{"name":"Department of Scientific Affairs, Tashkent State Dental Institute, 103 Makhtumkuli Str., Tashkent, Uzbekistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alsaikhan","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Alexis","family":"Ram\u00edrez-Coronel","sequence":"additional","affiliation":[{"name":"Azogues Campus Nursing\nCareer, Health and Behavior Research Group (HBR), Psychometry and Ethology Laboratory, Catholic\nUniversity of Cuenca, Cuenca, Ecuador"},{"name":"Epidemiology and Biostatistics Research Group, CES University,\nMedellin, Colombia"},{"name":"Educational Statistics Research Group (GIEE), National University of Education,\nCuenca, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpamala","family":"Ramaiah","sequence":"additional","affiliation":[{"name":"Faculty of Nursing, Umm al-Qura University, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Najafi","sequence":"additional","affiliation":[{"name":"Medical Technology Research Center, Institute of Health Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","volume":"133","author":"Koene R.J.","year":"2016","unstructured":"Koene R.J.; Prizment A.E.; Blaes A.; Konety S.H.; Shared risk factors in cardiovascular disease and cancer. Circulation  2016,133(11),1104-1114","journal-title":"Circulation"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1177\/17588359211018047","volume":"13","author":"Das S.","year":"2021","unstructured":"Das S.; Dasari A.; Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors. Ther Adv Med Oncol  2021,13","journal-title":"Ther Adv Med Oncol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejca.2022.12.031","volume":"182","author":"Das S.","year":"2023","unstructured":"Das S.; Phillips S.; Lee C.L.; Agarwal R.; Bergsland E.; Strosberg J.; Chan J.A.; LaFerriere H.; Ramirez R.A.; Berlin J.; Dasari A.; Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours \u2013 A systematic review and meta-analysis. Eur J Cancer  2023,182,43-52","journal-title":"Eur J Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.radonc.2016.07.013","volume":"120","author":"Popp I.","year":"2016","unstructured":"Popp I.; Grosu A.L.; Niedermann G.; Duda D.G.; Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications. Radiother Oncol  2016,120(2),185-194","journal-title":"Radiother Oncol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11912-020-00986-9","volume":"22","author":"Lubas M.J.","year":"2020","unstructured":"Lubas M.J.; Kumar S.S.; The combined use of SBRT and immunotherapy\u2014a literature review. Curr Oncol Rep  2020,22(12),117","journal-title":"Curr Oncol Rep"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.2147\/DDDT.S176879","volume":"12","author":"Yang F.","year":"2018","unstructured":"Yang F.; Li A.; Liu H.; Zhang H.; Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity. Drug Des Devel Ther  2018,12,3321-3333","journal-title":"Drug Des Devel Ther"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00520-006-0047-4","volume":"14","author":"Bensadoun R.J.","year":"2006","unstructured":"Bensadoun R.J.; Schubert M.M.; Lalla R.V.; Keefe D.; Amifostine in the management of radiation-induced and chemo-induced mucositis. Support Care Cancer  2006,14(6),566-572","journal-title":"Support Care Cancer"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.radonc.2003.10.005","volume":"70","author":"Rades D.","year":"2004","unstructured":"Rades D.; Fehlauer F.; Bajrovic A.; Mahlmann B.; Richter E.; Alberti W.; Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiother Oncol  2004,70(3),261-264","journal-title":"Radiother Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1634\/theoncologist.12-6-738","volume":"12","author":"Kouvaris J.R.","year":"2007","unstructured":"Kouvaris J.R.; Kouloulias V.E.; Vlahos L.J.; Amifostine: The first selective-target and broad-spectrum radioprotector. Oncologist  2007,12(6),738-747","journal-title":"Oncologist"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2019.03.022","volume":"452","author":"Fernando W.","year":"2019","unstructured":"Fernando W.; Rupasinghe H.P.V.; Hoskin D.W.; Dietary phytochemicals with anti-oxidant and pro-oxidant activities: A double-edged sword in relation to adjuvant chemotherapy and radiotherapy? Cancer Lett  2019,452,168-177","journal-title":"Cancer Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12015-018-9866-1","volume":"15","author":"Golchin A.","year":"2019","unstructured":"Golchin A.; Farahany T.Z.; Biological products: Cellular therapy and FDA approved products. Stem Cell Rev  2019,15(2),166-175","journal-title":"Stem Cell Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.phytol.2019.04.003","volume":"31","author":"Majolo F.","year":"2019","unstructured":"Majolo F.; de Oliveira Becker Delwing L.K.; Marmitt D.J.; Bustamante-Filho I.C.; Goettert M.I.; Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery. Phytochem Lett  2019,31,196-207","journal-title":"Phytochem Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10495-022-01750-z","volume":"27","author":"Zhao S.","year":"2022","unstructured":"Zhao S.; Tang Y.; Wang R.; Najafi M.; Mechanisms of cancer cell death induction by paclitaxel: An updated review. Apoptosis  2022,27(9-10),647-667","journal-title":"Apoptosis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41401-020-00508-0","volume":"41","author":"Ma R.","year":"2020","unstructured":"Ma R.; Yi B.; Riker A.I.; Xi Y.; Metformin and cancer immunity. Acta Pharmacol Sin  2020,41(11),1403-1409","journal-title":"Acta Pharmacol Sin"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2174\/1871520620666200918102642","volume":"21","author":"Tang Z.","year":"2021","unstructured":"Tang Z.; Tang N.; Jiang S.; Bai Y.; Guan C.; Zhang W.; Fan S.; Huang Y.; Lin H.; Ying Y.; The chemosensitizing role of metformin in anti-cancer therapy. Anticancer Agents Med Chem  2021,21(8),949-962","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"11684","DOI":"10.1038\/s41598-021-91174-7","volume":"11","author":"Sutkowska E.","year":"2021","unstructured":"Sutkowska E.; Fortuna P.; Wisniewski J.; Sutkowska K.; Hodurek P.; Gamian A.; Kaluza B.; Low metformin dose and its therapeutic serum concentration in prediabetes. Sci Rep  2021,11(1),11684","journal-title":"Sci Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcte.2018.05.001","volume":"12","author":"Ningrum V.D.A.","year":"2018","unstructured":"Ningrum V.D.A.; Ikawati Z.; Sadewa A.H.; Ikhsan M.R.; Patient-factors associated with metformin steady-state levels in type 2 diabetes mellitus with therapeutic dosage. J Clin Transl Endocrinol  2018,12,42-47","journal-title":"J Clin Transl Endocrinol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrgentox.2018.01.007","volume":"827","author":"Najafi M.","year":"2018","unstructured":"Najafi M.; Cheki M.; Rezapoor S.; Geraily G.; Motevaseli E.; Carnovale C.; Clementi E.; Shirazi A.; Metformin: Prevention of genomic instability and cancer: A review. Mutat Res Genet Toxicol Environ Mutagen  2018,827,1-8","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/ph14060545","volume":"14","author":"Jeong Y.S.","year":"2021","unstructured":"Jeong Y.S.; Jusko W.J.; Meta-assessment of metformin absorption and disposition pharmacokinetics in nine species. Pharmaceuticals  2021,14(6),545","journal-title":"Pharmaceuticals"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.ejca.2010.06.012","volume":"46","author":"Jalving M.","year":"2010","unstructured":"Jalving M.; Gietema J.A.; Lefrandt J.D.; Jong S.; Reyners A.K.L.; Gans R.O.B.; Vries E.G.E.; Metformin: Taking away the candy for cancer? Eur J Cancer  2010,46(13),2369-2380","journal-title":"Eur J Cancer"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2147\/CMAR.S200059","volume":"11","author":"Saraei P.","year":"2019","unstructured":"Saraei P.; Asadi I.; Kakar M.A.; Moradi-Kor N.; The beneficial effects of metformin on cancer prevention and therapy: A comprehensive review of recent advances. Cancer Manag Res  2019,11,3295-3313","journal-title":"Cancer Manag Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","volume":"3","author":"DeCensi A.","year":"2010","unstructured":"DeCensi A.; Puntoni M.; Goodwin P.; Cazzaniga M.; Gennari A.; Bonanni B.; Gandini S.; Metformin and cancer risk in diabetic patients: A systematic review and meta-analysis. Cancer Prev Res  2010,3(11),1451-1461","journal-title":"Cancer Prev Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fendo.2019.00294","volume":"10","author":"vial G.","year":"2019","unstructured":"vial G.; Detaille D.; Guigas B.; Role of mitochondria in the mechanism(s) of action of metformin. Front Endocrinol  2019,10,294","journal-title":"Front Endocrinol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fendo.2018.00753","volume":"9","author":"Fontaine E.","year":"2018","unstructured":"Fontaine E.; Metformin-induced mitochondrial complex I inhibition: Facts, uncertainties, and consequences. Front Endocrinol  2018,9,753","journal-title":"Front Endocrinol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/REP-09-0351","volume":"139","author":"Tosca L.","year":"2010","unstructured":"Tosca L.; Ram\u00e9 C.; Chabrolle C.; Tesseraud S.; Dupont J.; Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells. Reproduction  2010,139(2),409-418","journal-title":"Reproduction"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"117570","DOI":"10.1016\/j.lfs.2020.117570","volume":"250","author":"Farhood B.","year":"2020","unstructured":"Farhood B.; Ashrafizadeh M.; khodamoradi E.; Hoseini-Ghahfarokhi M.; Afrashi S.; Musa A.E.; Najafi M.; Targeting of cellular redox metabolism for mitigation of radiation injury. Life Sci  2020,250,117570","journal-title":"Life Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"153402","DOI":"10.1016\/j.phymed.2020.153402","volume":"80","author":"Liu Y.Q.","year":"2021","unstructured":"Liu Y.Q.; Wang X.L.; He D.H.; Cheng Y.X.; Protection against chemotherapy- and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine  2021,80,153402","journal-title":"Phytomedicine"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"10126","DOI":"10.3390\/ijms221810126","volume":"22","author":"Boopathi E.","year":"2021","unstructured":"Boopathi E.; Thangavel C.; Dark side of cancer therapy: Cancer treatment-induced cardiopulmonary inflammation, fibrosis, and immune modulation. Int J Mol Sci  2021,22(18),10126","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"106761","DOI":"10.1016\/j.intimp.2020.106761","volume":"86","author":"Ashrafizadeh M.","year":"2020","unstructured":"Ashrafizadeh M.; Farhood B.; Eleojo Musa A.; Taeb S.; Najafi M.; Damage-associated molecular patterns in tumor radiotherapy. Int Immunopharmacol  2020,86,106761","journal-title":"Int Immunopharmacol"},{"key":"ref=31","first-page":"649747","volume":"2013","author":"Veiko N.N.","year":"2013","unstructured":"Veiko N.N.; Oxidized extracellular DNA as a stress signal in human cells. Oxid Med Cell Longev  2013,2013,649747","journal-title":"Oxid Med Cell Longev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-022-04502-4","volume":"478","author":"Wu X.","year":"2023","unstructured":"Wu X.; Xu W.W.; Huan X.; Wu G.; Li G.; Zhou Y.H.; Najafi M.; Mechanisms of cancer cell killing by metformin: a review on different cell death pathways. Mol Cell Biochem  2023,478(1),197-214","journal-title":"Mol Cell Biochem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10495-022-01721-4","volume":"27","author":"Huang J.","year":"2022","unstructured":"Huang J.; Chang Z.; Lu Q.; Chen X.; Najafi M.; Nobiletin as an inducer of programmed cell death in cancer: A review. Apoptosis  2022,27(5-6),297-310","journal-title":"Apoptosis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"a008748","DOI":"10.1101\/cshperspect.a008748","volume":"5","author":"Hochreiter-Hufford A.","year":"2013","unstructured":"Hochreiter-Hufford A.; Ravichandran K.S.; Clearing the dead: Apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol  2013,5(1),a008748","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"101275","DOI":"10.1016\/j.smim.2019.04.003","volume":"Vol. 40","author":"Prata L.G.L.","year":"2018","unstructured":"Prata L.G.L.; Ovsyannikova I.G.; Tchkonia T.; Kirkland J.L.;  In Semin Immunol  2018,Vol. 40,101275","journal-title":"In Semin Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.3390\/ijms20205002","volume":"20","author":"Tominaga K.","year":"2019","unstructured":"Tominaga K.; Suzuki H.I.; TGF-\u03b2 signaling in cellular senescence and aging-related pathology. Int J Mol Sci  2019,20(20),5002","journal-title":"Int J Mol Sci"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"Marchi S.","year":"2022","unstructured":"Marchi S.; Guilbaud E.; Tait S.W.; Yamazaki T.; Galluzzi L.; Mitochondrial control of inflammation. Nat Rev Immunol  2022,23(3),159-173","journal-title":"Nat Rev Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","volume":"38","author":"Pandolfi F.","year":"2016","unstructured":"Pandolfi F.; Altamura S.; Frosali S.; Conti P.; Key role of DAMP in inflammation, cancer, and tissue repair. Clin Ther  2016,38(5),1017-1028","journal-title":"Clin Ther"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"Gong T.","year":"2020","unstructured":"Gong T.; Liu L.; Jiang W.; Zhou R.; DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol  2020,20(2),95-112","journal-title":"Nat Rev Immunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2174\/1389450123666220705123315","volume":"23","author":"Lai X.","year":"2022","unstructured":"Lai X.; Najafi M.; Redox interactions in chemo\/radiation therapy-induced lung toxicity; Mechanisms and therapy perspectives. Curr Drug Targets  2022,23(13),1261-1276","journal-title":"Curr Drug Targets"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s00018-020-03479-x","volume":"77","author":"khodamoradi E.","year":"2020","unstructured":"khodamoradi E.; Hoseini-Ghahfarokhi M.; Amini P.; Motevaseli E.; Shabeeb D.; Musa A.E.; Najafi M.; Farhood B.; Targets for protection and mitigation of radiation injury. Cell Mol Life Sci  2020,77(16),3129-3159","journal-title":"Cell Mol Life Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"154184","DOI":"10.1016\/j.phymed.2022.154184","volume":"102","author":"Yang C.","year":"2022","unstructured":"Yang C.; Song C.; Wang Y.; Zhou W.; Zheng W.; Zhou H.; Deng G.; Li H.; Xiao W.; Yang Z.; Kong L.; Ge H.; Song Y.; Sun Y.; Re-Du-Ning injection ameliorates radiation-induced pneumonitis and fibrosis by inhibiting AIM2 inflammasome and epithelial-mesenchymal transition. Phytomedicine  2022,102,154184","journal-title":"Phytomedicine"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/md14100182","volume":"14","author":"Yu D.","year":"2016","unstructured":"Yu D.; Li S.; Wang S.; Li X.; Zhu M.; Huang S.; Sun L.; Zhang Y.; Liu Y.; Wang S.; Development and characterization of VEGF165-chitosan nanoparticles for the treatment of radiation-induced skin injury in rats. Mar Drugs  2016,14(10),182","journal-title":"Mar Drugs"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1097\/SAP.0000000000002098","volume":"83","author":"Borrelli M.R.","year":"2019","unstructured":"Borrelli M.R.; Shen A.H.; Lee G.K.; Momeni A.; Longaker M.T.; Wan D.C.; Radiation-induced skin fibrosis: Pathogenesis, current treatment options, and emerging therapeutics. Ann Plast Surg  2019,83(4S)(Suppl. 1),S59-S64","journal-title":"Ann Plast Surg"},{"key":"ref=45","first-page":"2509","author":"Cohn S.M.","year":"2015","unstructured":"Cohn S.M.; Vidrich A.; Bickston S.J.;  Radiation injury in the gastrointestinal tract  2015,2509-2520","journal-title":"Radiation injury in the gastrointestinal tract"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jfma.2012.10.021","volume":"114","author":"Chen C.C.","year":"2015","unstructured":"Chen C.C.; Wang L.; Lin J.C.; Jan J.S.; The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy. J Formos Med Assoc  2015,114(3),231-237","journal-title":"J Formos Med Assoc"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2174\/1389450123666220907144131","volume":"23","author":"Xu C.","year":"2022","unstructured":"Xu C.; Najafi M.; Shang Z.; lung pneumonitis and fibrosis in cancer therapy: A review on cellular and molecular mechanisms. Curr Drug Targets  2022,23(16),1505-1525","journal-title":"Curr Drug Targets"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"108952","DOI":"10.1016\/j.abb.2021.108952","volume":"708","author":"Fu X.","year":"2021","unstructured":"Fu X.; Tang J.; Wen P.; Huang Z.; Najafi M.; Redox interactions-induced cardiac toxicity in cancer therapy. Arch Biochem Biophys  2021,708,108952","journal-title":"Arch Biochem Biophys"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jtho.2019.02.026","volume":"14","author":"Altan M.","year":"2019","unstructured":"Altan M.; Toki M.I.; Gettinger S.N.; Carvajal-Hausdorf D.E.; Zugazagoitia J.; Sinard J.H.; Herbst R.S.; Rimm D.L.; Immune checkpoint inhibitor\u2013associated pericarditis. J Thorac Oncol  2019,14(6),1102-1108","journal-title":"J Thorac Oncol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"100420","DOI":"10.1016\/j.ijcha.2019.100420","volume":"25","author":"Michel L.","year":"2019","unstructured":"Michel L.; Rassaf T.; Totzeck M.; Cardiotoxicity from immune checkpoint inhibitors. Int J Cardiol Heart Vasc  2019,25,100420","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/ars.2016.6748","volume":"26","author":"Klein D.","year":"2017","unstructured":"Klein D.; Steens J.; Wiesemann A.; Schulz F.; Kaschani F.; R\u00f6ck K.; Yamaguchi M.; Wirsd\u00f6rfer F.; Kaiser M.; Fischer J.W.; Stuschke M.; Jendrossek V.; Mesenchymal stem cell therapy protects lungs from radiation-induced endothelial cell loss by restoring superoxide dismutase 1 expression. Antioxid Redox Signal  2017,26(11),563-582","journal-title":"Antioxid Redox Signal"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1667\/RR14874.1","volume":"189","author":"Groves A.M.","year":"2018","unstructured":"Groves A.M.; Johnston C.J.; Williams J.P.; Finkelstein J.N.; Role of infiltrating monocytes in the development of radiation-induced pulmonary fibrosis. Radiat Res  2018,189(3),300-311","journal-title":"Radiat Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/14737140.2018.1500180","volume":"18","author":"Li L.","year":"2018","unstructured":"Li L.; Mok H.; Jhaveri P.; Bonnen M.D.; Sikora A.G.; Eissa N.T.; Komaki R.U.; Ghebre Y.T.; Anticancer therapy and lung injury: Molecular mechanisms. Expert Rev Anticancer Ther  2018,18(10),1041-1057","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccm.2017.01.002","volume":"38","author":"Leger P.","year":"2017","unstructured":"Leger P.; Limper A.H.; Maldonado F.; Pulmonary toxicities from conventional chemotherapy. Clin Chest Med  2017,38(2),209-222","journal-title":"Clin Chest Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","volume":"141","author":"Straub J.M.","year":"2015","unstructured":"Straub J.M.; New J.; Hamilton C.D.; Lominska C.; Shnayder Y.; Thomas S.M.; Radiation-induced fibrosis: Mechanisms and implications for therapy. J Cancer Res Clin Oncol  2015,141(11),1985-1994","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/medicina55080417","volume":"55","author":"Farhood B.","year":"2019","unstructured":"Farhood B.; Aliasgharzadeh A.; Amini P.; Rezaeyan A.; Tavassoli A.; Motevaseli E.; Shabeeb D.; Eleojo Musa A.; Najafi M.; Mitigation of radiation-induced lung pneumonitis and fibrosis using metformin and melatonin: A histopathological study. Medicina  2019,55(8),417","journal-title":"Medicina"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/2589977511666191018180758","volume":"11","author":"Yahyapour R.","year":"2019","unstructured":"Yahyapour R.; Amini P.; Saffar H.; Motevaseli E.; Farhood B.; Pooladvand V.; Shabeeb D.; Musa A.E.; Najafi M.; Protective effect of metformin, resveratrol and alpha-lipoic acid on radiation- induced pneumonitis and fibrosis: A histopathological study. Curr Drug Res Rev  2019,11(2),111-117","journal-title":"Curr Drug Res Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15171\/apb.2018.078","volume":"8","author":"Azmoonfar R.","year":"2018","unstructured":"Azmoonfar R.; Amini P.; Saffar H.; Rezapoor S.; Motevaseli E.; Cheki M.; Yahyapour R.; farhood B.; Nouruzi F.; Khodamoradi E.; Shabeeb D.; Eleojo Musa A.; Najafi M.; Metformin protects against radiation-induced pneumonitis and fibrosis and attenuates upregulation of dual oxidase genes expression. Adv Pharm Bull  2018,8(4),697-704","journal-title":"Adv Pharm Bull"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"39714","DOI":"10.1038\/srep39714","volume":"6","author":"Chung S.I.","year":"2016","unstructured":"Chung S.I.; Horton J.A.; Ramalingam T.R.; White A.O.; Chung E.J.; Hudak K.E.; Scroggins B.T.; Arron J.R.; Wynn T.A.; Citrin D.E.; IL-13 is a therapeutic target in radiation lung injury. Sci Rep  2016,6(1),39714","journal-title":"Sci Rep"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1080\/09553002.2016.1222094","volume":"92","author":"Groves A.M.","year":"2016","unstructured":"Groves A.M.; Johnston C.J.; Misra R.S.; Williams J.P.; Finkelstein J.N.; Effects of IL-4 on pulmonary fibrosis and the accumulation and phenotype of macrophage subpopulations following thoracic irradiation. Int J Radiat Biol  2016,92(12),754-765","journal-title":"Int J Radiat Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1165\/ajrcmb.17.3.2279","volume":"17","author":"B\u00fcttner C.","year":"1997","unstructured":"B\u00fcttner C.; Skupin A.; Reimann T.; Rieber E.P.; Unteregger G.; Geyer P.; Frank K.H.; Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: Macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol  1997,17(3),315-325","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.21873\/invivo.11668","volume":"33","author":"Park H.R.","year":"2019","unstructured":"Park H.R.; Jo S.K.; Jung U.; Ionizing radiation promotes epithelial\u2013to\u2013mesenchymal transition in lung epithelial cells by TGF-\u03b2-producing M2 macrophages. In Vivo  2019,33(6),1773-1784","journal-title":"In Vivo"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.4049\/jimmunol.171.5.2684","volume":"171","author":"Jakubzick C.","year":"2003","unstructured":"Jakubzick C.; Choi E.S.; Joshi B.H.; Keane M.P.; Kunkel S.L.; Puri R.K.; Hogaboam C.M.; Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol  2003,171(5),2684-2693","journal-title":"J Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/mi.2015.56","volume":"9","author":"Karo-Atar D.","year":"2016","unstructured":"Karo-Atar D.; Bordowitz A.; Wand O.; Pasmanik-Chor M.; Fernandez I.E.; Itan M.; Frenkel R.; Herbert D.R.; Finkelman F.D.; Eickelberg O.; Munitz A.; A protective role for IL-13 receptor \u03b1 1 in bleomycin-induced pulmonary injury and repair. Mucosal Immunol  2016,9(1),240-253","journal-title":"Mucosal Immunol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1667\/RR14708.1","volume":"188","author":"Wang J.","year":"2017","unstructured":"Wang J.; Wang Y.; Han J.; Mei H.; Yu D.; Ding Q.; Zhang T.; Wu G.; Peng G.; Lin Z.; Metformin attenuates radiation-induced pulmonary fibrosis in a murine model. Radiat Res  2017,188(1),105-113","journal-title":"Radiat Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.critrevonc.2016.06.001","volume":"105","author":"Shahid S.","year":"2016","unstructured":"Shahid S.; Review of hematological indices of cancer patients receiving combined chemotherapy and radiotherapy or receiving radiotherapy alone. Crit Rev Oncol Hematol  2016,105,145-155","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.2147\/CMAR.S195989","volume":"11","author":"Kumar T.","year":"2019","unstructured":"Kumar T.; Schernberg A.; Busato F.; Laurans M.; Fumagalli I.; Dumas I.; Deutsch E.; Haie-Meder C.; Chargari C.; Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation. Cancer Manag Res  2019,11,6285-6297","journal-title":"Cancer Manag Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1667\/RR13887.1","volume":"183","author":"Chang J.","year":"2015","unstructured":"Chang J.; Feng W.; Wang Y.; Luo Y.; Allen A.R.; Koturbash I.; Turner J.; Stewart B.; Raber J.; Hauer-Jensen M.; Zhou D.; Shao L.; Whole-body proton irradiation causes long-term damage to hematopoietic stem cells in mice. Radiat Res  2015,183(2),240-248","journal-title":"Radiat Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.freeradbiomed.2009.11.005","volume":"48","author":"Wang Y.","year":"2010","unstructured":"Wang Y.; Liu L.; Pazhanisamy S.K.; Li H.; Meng A.; Zhou D.; Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radic Biol Med  2010,48(2),348-356","journal-title":"Free Radic Biol Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2012.10.530","volume":"54","author":"Zhang H.","year":"2013","unstructured":"Zhang H.; Zhai Z.; Wang Y.; Zhang J.; Wu H.; Wang Y.; Li C.; Li D.; Lu L.; Wang X.; Chang J.; Hou Q.; Ju Z.; Zhou D.; Meng A.; Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med  2013,54,40-50","journal-title":"Free Radic Biol Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jrr\/rrs142","volume":"54","author":"Zhang H.","year":"2013","unstructured":"Zhang H.; Wang Y.; Meng A.; Yan H.; Wang X.; Niu J.; Li J.; Wang H.; Inhibiting TGF\u03b21 has a protective effect on mouse bone marrow suppression following ionizing radiation exposure in vitro. J Radiat Res  2013,54(4),630-636","journal-title":"J Radiat Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mrgentox.2016.09.001","volume":"809","author":"Cheki M.","year":"2016","unstructured":"Cheki M.; Shirazi A.; Mahmoudzadeh A.; Bazzaz J.T.; Hosseinimehr S.J.; The radioprotective effect of metformin against cytotoxicity and genotoxicity induced by ionizing radiation in cultured human blood lymphocytes. Mutat Res Genet Toxicol Environ Mutagen  2016,809,24-32","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1574884713666181025141559","volume":"14","author":"Mortezaee K.","year":"2019","unstructured":"Mortezaee K.; Shabeeb D.; Musa A.E.; Najafi M.; Farhood B.; Metformin as a radiation modifier; Implications to normal tissue protection and tumor sensitization. Curr Clin Pharmacol  2019,14(1),41-53","journal-title":"Curr Clin Pharmacol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2015.05.045","volume":"87","author":"Xu G.","year":"2015","unstructured":"Xu G.; Wu H.; Zhang J.; Li D.; Wang Y.; Wang Y.; Zhang H.; Lu L.; Li C.; Huang S.; Xing Y.; Zhou D.; Meng A.; Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med  2015,87,15-25","journal-title":"Free Radic Biol Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2147\/CCID.S94320","volume":"9","author":"Spa\u0142ek M.","year":"2016","unstructured":"Spa\u0142ek M.; Chronic radiation-induced dermatitis: Challenges and solutions. Clin Cosmet Investig Dermatol  2016,9,473-482","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/BCTT.S109763","volume":"9","author":"Kole A.J.","year":"2017","unstructured":"Kole A.J.; Kole L.; Moran M.; Acute radiation dermatitis in breast cancer patients: Challenges and solutions. Breast Cancer  2017,9,313-323","journal-title":"Breast Cancer"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1177\/1534735420962174","volume":"19","author":"Ferreira E.B.","year":"2020","unstructured":"Ferreira E.B.; Ciol M.A.; de Meneses A.G.; Bontempo P.S.M.; Hoffman J.M.; Reis P.E.D.; Chamomile gel versus urea cream to prevent acute radiation dermatitis in head and neck cancer patients: Results from a preliminary clinical trial. Integr Cancer Ther  2020,19","journal-title":"Integr Cancer Ther"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13014-018-1004-3","volume":"13","author":"Liang X.","year":"2018","unstructured":"Liang X.; Bradley J.A.; Zheng D.; Rutenberg M.; Yeung D.; Mendenhall N.; Li Z.; Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer. Radiat Oncol  2018,13(1),72","journal-title":"Radiat Oncol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/1874471012666181120163250","volume":"12","author":"Shabeeb D.","year":"2019","unstructured":"Shabeeb D.; Najafi M.; Musa A.E.; Keshavarz M.; Shirazi A.; Hassanzadeh G.; Hadian M.R.; Samandari H.; Biochemical and histopathological evaluation of the radioprotective effects of melatonin against gamma ray-induced skin damage. Curr Radiopharm  2019,12(1),72-81","journal-title":"Curr Radiopharm"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1159\/000491964","volume":"48","author":"Kim J.M.","year":"2018","unstructured":"Kim J.M.; Yoo H.; Kim J.Y.; Oh S.H.; Kang J.W.; Yoo B.R.; Han S.Y.; Kim C.S.; Choi W.H.; Lee E.J.; Byeon H.J.; Lee W.J.; Lee Y.S.; Cho J.; Metformin alleviates radiation-induced skin fibrosis via the downregulation of FOXO3. Cell Physiol Biochem  2018,48(3),959-970","journal-title":"Cell Physiol Biochem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3748\/wjg.v13.i22.3043","volume":"13","author":"Moll\u00e0 M.","year":"2007","unstructured":"Moll\u00e0 M.; Pan\u00e9s J.; Radiation-induced intestinal inflammation. World J Gastroenterol  2007,13(22),3043-3046","journal-title":"World J Gastroenterol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.3748\/wjg.v13.i22.3047","volume":"13","author":"Wang J.","year":"2007","unstructured":"Wang J.; Boerma M.; Fu Q.; HauerJensen M.; Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J Gastroenterol  2007,13(22),3047-3055","journal-title":"World J Gastroenterol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/156652409787847164","volume":"9","author":"Gervaz P.","year":"2009","unstructured":"Gervaz P.; Morel P.; Vozenin-Brotons M.C.; Molecular aspects of intestinal radiation-induced fibrosis. Curr Mol Med  2009,9(3),273-280","journal-title":"Curr Mol Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3748\/wjg.v19.i2.185","volume":"19","author":"Shadad A.K.","year":"2013","unstructured":"Shadad A.K.; Sullivan F.J.; Martin J.D.; Egan L.J.; Gastrointestinal radiation injury: Symptoms, risk factors and mechanisms. World J Gastroenterol  2013,19(2),185-198","journal-title":"World J Gastroenterol"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.5812\/jjnpp.67352","volume":"14","author":"Bagheri H.","year":"2019","unstructured":"Bagheri H.; Rezapoor S.; Najafi M.; Safar H.; Shabeeb D.; Cheki M.; Shekarchi B.; Motevaseli E.; Metformin protects the rat small intestine against radiation enteritis. Jundishapur J Nat Pharm Prod  2019,14(4)","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1208\/s12249-021-01941-y","volume":"22","author":"Uthaiwat P.","year":"2021","unstructured":"Uthaiwat P.; Priprem A.; Chio-Srichan S.; Settasatian C.; Lee Y.C.; Mahakunakorn P.; Boonsiri P.; Leelayuwat C.; Tippayawat P.; Puthongking P.; Daduang J.; Oral administration of melatonin or succinyl melatonin niosome gel benefits 5-fu-induced small intestinal mucositis treatment in mice. AAPS PharmSciTech  2021,22(5),200","journal-title":"AAPS PharmSciTech"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/1567201817666200525151848","volume":"18","author":"Uthaiwat P.","year":"2021","unstructured":"Uthaiwat P.; Daduang J.; Priprem A.; Settasatian C.; Chio-Srichan S.; Lee Y.C.; Mahakunakorn P.; Boonsiri P.; Topical melatonin niosome gel for the treatment of 5-fu-induced oral mucositis in mice. Curr Drug Deliv  2021,18(2),199-211","journal-title":"Curr Drug Deliv"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s12094-021-02586-w","volume":"23","author":"Lozano A.","year":"2021","unstructured":"Lozano A.; Marruecos J.; Rubi\u00f3 J.; Farr\u00e9 N.; G\u00f3mez-Mill\u00e1n J.; Morera R.; Planas I.; Lanzuela M.; V\u00e1zquez-Masedo M.G.; Cascallar L.; Giralt J.; Escames G.; Valent\u00ed V.; Grima P.; Bosser R.; Tarrag\u00f3 C.; Mes\u00eda R.; Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment. Clin Transl Oncol  2021,23(9),1801-1810","journal-title":"Clin Transl Oncol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13046-020-01715-7","volume":"39","author":"Pulito C.","year":"2020","unstructured":"Pulito C.; Cristaudo A.; Porta C.L.; Zapperi S.; Blandino G.; Morrone A.; Strano S.; Oral mucositis: The hidden side of cancer therapy. J Exp Clin Cancer Res  2020,39(1),210","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"106182","DOI":"10.1016\/j.ejps.2022.106182","volume":"173","author":"Sun H.","year":"2022","unstructured":"Sun H.; Zhou Y.; Ma R.; Zhang J.; Shan J.; Chen Y.; Li X.; Shan E.; Metformin protects 5-Fu-induced chemotherapy oral mucositis by reducing endoplasmic reticulum stress in mice. Eur J Pharm Sci  2022,173,106182","journal-title":"Eur J Pharm Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"109342","DOI":"10.1016\/j.intimp.2022.109342","volume":"113","author":"Xia J.","year":"2022","unstructured":"Xia J.; Chen J.; Vashisth M.K.; Ge Y.; Dai Q.; He S.; Shi Y.; Wang X.; Metformin ameliorates 5-fluorouracil-induced intestinal injury by inhibiting cellular senescence, inflammation, and oxidative stress. Int Immunopharmacol  2022,113(Pt A),109342","journal-title":"Int Immunopharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1089\/ars.2019.7842","volume":"31","author":"Mercurio V.","year":"2019","unstructured":"Mercurio V.; Cuomo A.; Della Pepa R.; Ciervo D.; Cella L.; Pirozzi F.; Parrella P.; Campi G.; Franco R.; Varricchi G.; Abete P.; Marone G.; Petretta M.; Bonaduce D.; Pacelli R.; Picardi M.; Tocchetti C.G.; What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients? Antioxid Redox Signal  2019,31(15),1166-1174","journal-title":"Antioxid Redox Signal"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7582730","volume":"2018","author":"Gorini S.","year":"2018","unstructured":"Gorini S.; De Angelis A.; Berrino L.; Malara N.; Rosano G.; Ferraro E.; Chemotherapeutic drugs and mitochondrial dysfunction: Focus on doxorubicin, trastuzumab, and sunitinib. Oxid Med Cell Longev  2018,2018,1-15","journal-title":"Oxid Med Cell Longev"},{"key":"ref=94","first-page":"575","volume":"79","author":"Safaei A.","year":"2021","unstructured":"Safaei A.; Sheibani M.; Azizi Y.; A journey in anthracycline-induced cardiotoxicity with emphasizing on doxorubicin: a review article. Tehran Univ Medical J  2021,79(8),575-583","journal-title":"Tehran Univ Medical J"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/jcm11051244","volume":"11","author":"Fabin N.","year":"2022","unstructured":"Fabin N.; Bergami M.; Cenko E.; Bugiardini R.; Manfrini O.; The role of vasospasm and microcirculatory dysfunction in fluoropyrimidine-induced ischemic heart disease. J Clin Med  2022,11(5),1244","journal-title":"J Clin Med"},{"key":"ref=96","first-page":"8007","volume":"12","author":"Qi Y.","year":"2020","unstructured":"Qi Y.; Ying Y.; Zou J.; Fang Q.; Yuan X.; Cao Y.; Cai Y.; Fu S.; Kaempferol attenuated cisplatin-induced cardiac injury via inhibiting STING\/NF-\u03baB-mediated inflammation. Am J Transl Res  2020,12(12),8007-8018","journal-title":"Am J Transl Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10787-021-00894-9","volume":"30","author":"Yang R.","year":"2022","unstructured":"Yang R.; Tan C.; Najafi M.; Cardiac inflammation and fibrosis following chemo\/radiation therapy: Mechanisms and therapeutic agents. Inflammopharmacology  2022,30(1),73-89","journal-title":"Inflammopharmacology"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1080\/09553002.2021.1956007","volume":"97","author":"Wei T.","year":"2021","unstructured":"Wei T.; Cheng Y.; The cardiac toxicity of radiotherapy \u2013 a review of characteristics, mechanisms, diagnosis, and prevention. Int J Radiat Biol  2021,97(10),1333-1340","journal-title":"Int J Radiat Biol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fcvm.2020.00020","volume":"7","author":"Livingston K.","year":"2020","unstructured":"Livingston K.; Schlaak R.A.; Puckett L.L.; Bergom C.; The role of mitochondrial dysfunction in radiation-induced heart disease: from bench to bedside. Front Cardiovasc Med  2020,7,20","journal-title":"Front Cardiovasc Med"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.121.058411","volume":"146","author":"Dhingra R.","year":"2022","unstructured":"Dhingra R.; Rabinovich-Nikitin I.; Rothman S.; Guberman M.; Gang H.; Margulets V.; Jassal D.S.; Alagarsamy K.N.; Dhingra S.; Valenzuela Ripoll C.; Billia F.; Diwan A.; Javaheri A.; Kirshenbaum L.A.; Proteasomal degradation of TRAF2 mediates mitochondrial dysfunction in doxorubicin-cardiomyopathy. Circulation  2022,146(12),934-954","journal-title":"Circulation"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1007\/s11033-020-05582-5","volume":"47","author":"El kiki S.M.","year":"2020","unstructured":"El kiki S.M.; Omran M.M.; Mansour H.H.; Hasan H.F.; Metformin and\/or low dose radiation reduces cardiotoxicity and apoptosis induced by cyclophosphamide through SIRT-1\/SOD and BAX\/Bcl-2 pathways in rats. Mol Biol Rep  2020,47(7),5115-5126","journal-title":"Mol Biol Rep"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/1440-1681.13148","volume":"46","author":"Karam H.M.","year":"2019","unstructured":"Karam H.M.; Radwan R.R.; Metformin modulates cardiac endothelial dysfunction, oxidative stress and inflammation in irradiated rats: A new perspective of an antidiabetic drug. Clin Exp Pharmacol Physiol  2019,46(12),1124-1132","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=103","first-page":"193","volume":"7","author":"Yahyapour R.","year":"2018","unstructured":"Yahyapour R.; Amini P.; Saffar H.; Rezapoor S.; Motevaseli E.; Cheki M.; Farhood B.; Nouruzi F.; Shabeeb D.; Eleojo Musa A.; Najafi M.; Metformin protects against radiation-induced heart injury and attenuates the upregulation of dual oxidase genes following rat\u2019s chest irradiation. Int J Mol Cell Med  2018,7(3),193-202","journal-title":"Int J Mol Cell Med"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12012-022-09762-6","volume":"22","author":"Panpan T.","year":"2022","unstructured":"Panpan T.; Yuchen D.; Xianyong S.; Meng L.; Ruijuan H.; Ranran D.; Pengyan Z.; Mingxi L.; Rongrong X.; Cardiac remodelling following cancer therapy: A review. Cardiovasc Toxicol  2022,22(9),771-786","journal-title":"Cardiovasc Toxicol"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"A9375","DOI":"10.1161\/circ.144.suppl_1.9375","volume":"144","author":"Arinno A.","year":"2021","unstructured":"Arinno A.; Maneechote C.; Khuanjing T.; Chunchai T.; Prathumsap N.; Arunsak B.; Kerdphoo S.; Shinlapawittayatorn K.; Chattipakorn S.; Chattipakorn N.; Abstract 9375: Melatonin and metformin exert cardioprotection against trastuzumab-induced cardiotoxicity through modulating cardiac mitochondrial dynamics in rats. Circulation  2021,144(S1),A9375-A9375","journal-title":"Circulation"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"166618","DOI":"10.1016\/j.bbadis.2022.166618","volume":"1869","author":"Arinno A.","year":"2023","unstructured":"Arinno A.; Maneechote C.; Khuanjing T.; Prathumsap N.; Chunchai T.; Arunsak B.; Nawara W.; Kerdphoo S.; Shinlapawittayatorn K.; Chattipakorn S.C.; Chattipakorn N.; Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy. Biochim Biophys Acta Mol Basis Dis  2023,1869(2),166618","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/FJC.0000000000001256","volume":"79","author":"Kuburas R.","year":"2022","unstructured":"Kuburas R.; Gharanei M.; Haussmann I.; Maddock H.; Sandhu H.; Metformin protects against sunitinib-induced cardiotoxicity: Investigating the role of AMPK. J Cardiovasc Pharmacol  2022,79(6),799-807","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/0960327119888277","volume":"39","author":"Ajzashokouhi A.H.","year":"2020","unstructured":"Ajzashokouhi A.H.; Bostan H.B.; Jomezadeh V.; Hayes A.W.; Karimi G.; A review on the cardioprotective mechanisms of metformin against doxorubicin. Hum Exp Toxicol  2020,39(3),237-248","journal-title":"Hum Exp Toxicol"},{"key":"ref=109","first-page":"100","volume":"12","author":"Karim L.Z.A.","year":"2021","unstructured":"Karim L.Z.A.; Arif I.S.; Saady F.; Metabolomics Of metformin\u2019s cardioprotective effect in acute doxorubicin induced-cardiotoxicity in rats. Syst Rev Pharm  2021,12,100-109","journal-title":"Syst Rev Pharm"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"114004","DOI":"10.1016\/j.jep.2021.114004","volume":"274","author":"Ikewuchi J.C.","year":"2021","unstructured":"Ikewuchi J.C.; Ikewuchi C.C.; Ifeanacho M.O.; Jaja V.S.; Okezue E.C.; Jamabo C.N.; Adeku K.A.; Attenuation of doxorubicin-induced cardiotoxicity in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens. J Ethnopharmacol  2021,274,114004","journal-title":"J Ethnopharmacol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"114743","DOI":"10.1016\/j.bcp.2021.114743","volume":"192","author":"Arinno A.","year":"2021","unstructured":"Arinno A.; Maneechote C.; Khuanjing T.; Ongnok B.; Prathumsap N.; Chunchai T.; Arunsak B.; Kerdphoo S.; Shinlapawittayatorn K.; Chattipakorn S.C.; Chattipakorn N.; Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics. Biochem Pharmacol  2021,192,114743","journal-title":"Biochem Pharmacol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.5958\/0974-360X.2019.01007.2","volume":"12","author":"Shaty M.H.","year":"2019","unstructured":"Shaty M.H.; Al-Ezzi M.I.; Arif I.S.; Basil D.; Effect of metformin on inflammatory markers involved in cardiotoxicity induced by doxorubicin. Res J Pharm Technol  2019,12(12),5815-5821","journal-title":"Res J Pharm Technol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10557-020-06941-x","volume":"34","author":"Timm K.N.","year":"2020","unstructured":"Timm K.N.; Tyler D.J.; The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity. Cardiovasc Drugs Ther  2020,34(2),255-269","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"117498","DOI":"10.1016\/j.lfs.2020.117498","volume":"249","author":"Chen J.","year":"2020","unstructured":"Chen J.; Zhang S.; Pan G.; Lin L.; Liu D.; Liu Z.; Mei S.; Zhang L.; Hu Z.; Chen J.; Luo H.; Wang Y.; Xin Y.; You Z.; Modulatory effect of metformin on cardiotoxicity induced by doxorubicin via the MAPK and AMPK pathways. Life Sci  2020,249,117498","journal-title":"Life Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.18632\/aging.102787","volume":"12","author":"Chen K.","year":"2020","unstructured":"Chen K.; Li Y.; Guo Z.; Zeng Y.; Zhang W.; Wang H.; Metformin: Current clinical applications in nondiabetic patients with cancer. Aging  2020,12(4),3993-4009","journal-title":"Aging"},{"key":"ref=116","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920985632","volume":"13","author":"Rocca A.","year":"2021","unstructured":"Rocca A.; Cortesi P.; Cortesi L.; Gianni L.; Matteucci F.; Fantini L.; Maestri A.; Giunchi D.C.; Cavanna L.; Ciani R.; Falcini F.; Bagni A.; Meldoli E.; Dall\u2019Agata M.; Volpi R.; Andreis D.; Nanni O.; Curcio A.; Lucchi L.; Amadori D.; Fedeli A.; Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Ther Adv Med Oncol  2021,13","journal-title":"Ther Adv Med Oncol"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"A11469","DOI":"10.1161\/circ.146.suppl_1.11469","volume":"146","author":"Osataphan N.","year":"2022","unstructured":"Osataphan N.; Apaijai N.; Phrommintikul A.; LEEMASAWAT K.; Somwangprasert A.; Suksai S.; Chattipakorn S.; Chattipakorn N.; Abstract 11469: Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer patient: A randomized controlled trial. Circulation  2022,146(S1),A11469-A11469","journal-title":"Circulation"},{"key":"ref=118","first-page":"1017","volume":"9","author":"Yu J-M.","year":"2019","unstructured":"Yu J-M.; Hsieh M-C.; Qin L.; Zhang J.; Wu S-Y.; Metformin reduces radiation-induced cardiac toxicity risk in patients having breast cancer. Am J Cancer Res  2019,9(5),1017-1026","journal-title":"Am J Cancer Res"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"a026781","DOI":"10.1101\/cshperspect.a026781","volume":"7","author":"Hirata E.","year":"2017","unstructured":"Hirata E.; Sahai E.; Tumor microenvironment and differential responses to therapy. Cold Spring Harb Perspect Med  2017,7(7),a026781","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","volume":"10","author":"Melaiu O.","year":"2020","unstructured":"Melaiu O.; Lucarini V.; Cifaldi L.; Fruci D.; Influence of the tumor microenvironment on NK cell function in solid tumors. Front Immunol  2020,10,3038","journal-title":"Front Immunol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s13577-020-00380-4","volume":"33","author":"Katsuta E.","year":"2020","unstructured":"Katsuta E.; Rashid O.M.; Takabe K.; Clinical relevance of tumor microenvironment: Immune cells, vessels, and mouse models. Hum Cell  2020,33(4),930-937","journal-title":"Hum Cell"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"Thorsson V.","year":"2018","unstructured":"Thorsson V.; Gibbs D.L.; Brown S.D.; Wolf D.; Bortone D.S.; Yang T.-H.O.; Porta-Pardo E.; Gao G.F.; Plaisier C.L.; Eddy J.A.; The immune landscape of cancer. Immunity  2018,48(4),812-830. e814.","journal-title":"Immunity"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"632581","DOI":"10.3389\/fimmu.2021.632581","volume":"12","author":"Schreiber S.","year":"2021","unstructured":"Schreiber S.; Hammers C.M.; Kaasch A.J.; Schraven B.; Dudeck A.; Kahlfuss S.; Metabolic interdependency of Th2 cell-mediated type 2 immunity and the tumor microenvironment. Front Immunol  2021,12,632581","journal-title":"Front Immunol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/cells10071621","volume":"10","author":"Radomska-Le\u015bniewska D.M.","year":"2021","unstructured":"Radomska-Le\u015bniewska D.M.; Bia\u0142oszewska A.; Kami\u0144ski P.; Angiogenic properties of NK cells in cancer and other angiogenesis-dependent diseases. Cells  2021,10(7),1621","journal-title":"Cells"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00280-020-04092-2","volume":"86","author":"Tsukioki T.","year":"2020","unstructured":"Tsukioki T.; Shien T.; Tanaka T.; Suzuki Y.; Kajihara Y.; Hatono M.; Kawada K.; Kochi M.; Iwamoto T.; Ikeda H.; Taira N.; Doihara H.; Toyooka S.; Influences of preoperative metformin on immunological factors in early breast cancer. Cancer Chemother Pharmacol  2020,86(1),55-63","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1158\/1078-0432.CCR-20-0113","volume":"26","author":"Wang S.","year":"2020","unstructured":"Wang S.; Lin Y.; Xiong X.; Wang L.; Guo Y.; Chen Y.; Chen S.; Wang G.; Lin P.; Chen H.; Yeung S.C.J.; Bremer E.; Zhang H.; Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: Results of a phase II clinical trial. Clin Cancer Res  2020,26(18),4921-4932","journal-title":"Clin Cancer Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","volume":"43","author":"Patel D.D.","year":"2015","unstructured":"Patel D.D.; Kuchroo V.K.; Th17 cell pathway in human immunity: Lessons from genetics and therapeutic interventions. Immunity  2015,43(6),1040-1051","journal-title":"Immunity"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1038\/s41467-020-16363-w","volume":"11","author":"Perez L.G.","year":"2020","unstructured":"Perez L.G.; Kempski J.; McGee H.M.; Pelzcar P.; Agalioti T.; Giannou A.; Konczalla L.; Brockmann L.; Wahib R.; Xu H.; Vesely M.C.A.; Soukou S.; Steglich B.; Bedke T.; Manthey C.; Seiz O.; Diercks B.P.; Gnafakis S.; Guse A.H.; Perez D.; Izbicki J.R.; Gagliani N.; Flavell R.A.; Huber S.; TGF-\u03b2 signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer. Nat Commun  2020,11(1),2608","journal-title":"Nat Commun"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/jir.2018.0057","volume":"39","author":"Nalbant A.","year":"2019","unstructured":"Nalbant A.; IL-17, IL-21, and IL-22 Cytokines of T Helper 17 Cells in Cancer. J Interferon Cytokine Res  2019,39(1),56-60","journal-title":"J Interferon Cytokine Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","volume":"322","author":"Asadzadeh Z.","year":"2017","unstructured":"Asadzadeh Z.; Mohammadi H.; Safarzadeh E.; Hemmatzadeh M.; Mahdian-shakib A.; Jadidi-Niaragh F.; Azizi G.; Baradaran B.; The paradox of Th17 cell functions in tumor immunity. Cell Immunol  2017,322,15-25","journal-title":"Cell Immunol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1002\/ijc.29305","volume":"136","author":"Zhao D.","year":"2015","unstructured":"Zhao D.; Long X.D.; Lu T.F.; Wang T.; Zhang W.W.; Liu Y.X.; Cui X.L.; Dai H.J.; Xue F.; Xia Q.; Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma. Int J Cancer  2015,136(11),2556-2565","journal-title":"Int J Cancer"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.celrep.2017.04.004","volume":"19","author":"Limagne E.","year":"2017","unstructured":"Limagne E.; Thibaudin M.; Euvrard R.; Berger H.; Chalons P.; V\u00e9gan F.; Humblin E.; Boidot R.; R\u00e9b\u00e9 C.; Derang\u00e8re V.; Ladoire S.; Apetoh L.; Delmas D.; Ghiringhelli F.; Sirtuin-1 activation controls tumor growth by impeding Th17 differentiation via STAT3 deacetylation. Cell Rep  2017,19(4),746-759","journal-title":"Cell Rep"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"20706","DOI":"10.18632\/oncotarget.14982","volume":"8","author":"Chiang C.F.","year":"2017","unstructured":"Chiang C.F.; Chao T.T.; Su Y.F.; Hsu C.C.; Chien C.Y.; Chiu K.C.; Shiah S.G.; Lee C.H.; Liu S.Y.; Shieh Y.S.; Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-\u03baB signaling. Oncotarget  2017,8(13),20706-20718","journal-title":"Oncotarget"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"36441","DOI":"10.18632\/oncotarget.5541","volume":"6","author":"Ding L.","year":"2015","unstructured":"Ding L.; Liang G.; Yao Z.; Zhang J.; Liu R.; Chen H.; Zhou Y.; Wu H.; Yang B.; He Q.; Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages. Oncotarget  2015,6(34),36441-36455","journal-title":"Oncotarget"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ebiom.2017.10.009","volume":"25","author":"Kunisada Y.","year":"2017","unstructured":"Kunisada Y.; Eikawa S.; Tomonobu N.; Domae S.; Uehara T.; Hori S.; Furusawa Y.; Hase K.; Sasaki A.; Udono H.; Attenuation of CD4CD25 regulatory T cells in the tumor microenvironment by metformin, a type 2 diabetes drug. EBioMedicine  2017,25,154-164","journal-title":"EBioMedicine"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"E490","DOI":"10.1002\/lary.28336","volume":"130","author":"Amin D.","year":"2020","unstructured":"Amin D.; Richa T.; Mollaee M.; Zhan T.; Tassone P.; Johnson J.; Luginbuhl A.; Cognetti D.; Martinez-Outschoorn U.; Stapp R.; Solomides C.; Rodeck U.; Curry J.; Metformin effects on FOXP3  and CD8  T cell infiltrates of head and neck squamous cell carcinoma. Laryngoscope  2020,130(9),E490-E498","journal-title":"Laryngoscope"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"e1442167","DOI":"10.1080\/2162402X.2018.1442167","volume":"7","author":"Qin G.","year":"2018","unstructured":"Qin G.; Lian J.; Huang L.; Zhao Q.; Liu S.; Zhang Z.; Chen X.; Yue D.; Li L.; Li F.; Wang L.; Umansky V.; Zhang B.; Yang S.; Zhang Y.; Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis. OncoImmunology  2018,7(7),e1442167","journal-title":"OncoImmunology"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"109458","DOI":"10.1016\/j.biopha.2019.109458","volume":"120","author":"Xu P.","year":"2019","unstructured":"Xu P.; Yin K.; Tang X.; Tian J.; Zhang Y.; Ma J.; Xu H.; Xu Q.; Wang S.; Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Biomed Pharmacother  2019,120,109458","journal-title":"Biomed Pharmacother"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1158\/0008-5472.CAN-17-2460","volume":"78","author":"Li L.","year":"2018","unstructured":"Li L.; Wang L.; Li J.; Fan Z.; Yang L.; Zhang Z.; Zhang C.; Yue D.; Qin G.; Zhang T.; Li F.; Chen X.; Ping Y.; Wang D.; Gao Q.; He Q.; Huang L.; Li H.; Huang J.; Zhao X.; Xue W.; Sun Z.; Lu J.; Yu J.J.; Zhao J.; Zhang B.; Zhang Y.; Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer. Cancer Res  2018,78(7),1779-1791","journal-title":"Cancer Res"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"e0141392","DOI":"10.1371\/journal.pone.0141392","volume":"10","author":"Incio J.","year":"2015","unstructured":"Incio J.; Suboj P.; Chin S.M.; Vardam-Kaur T.; Liu H.; Hato T.; Babykutty S.; Chen I.; Deshpande V.; Jain R.K.; Fukumura D.; Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages. PLoS One  2015,10(12),e0141392","journal-title":"PLoS One"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"21570","DOI":"10.1038\/s41598-022-25065-w","volume":"12","author":"Abdelmoneim M.","year":"2022","unstructured":"Abdelmoneim M.; Eissa I.R.; Aboalela M.A.; Naoe Y.; Matsumura S.; Sibal P.A.; Bustos-Villalobos I.; Tanaka M.; Kodera Y.; Kasuya H.; Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model. Sci Rep  2022,12(1),21570","journal-title":"Sci Rep"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4161\/cc.11.5.19252","volume":"11","author":"Oliveras-Ferraros C.","year":"2012","unstructured":"Oliveras-Ferraros C.; Cuf\u00ed S.; Vazquez-Martin A.; Menendez O.J.; Bosch-Barrera J.; Martin-Castillo B.; Joven J.; Menendez J.A.; Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation. Cell Cycle  2012,11(5),865-870","journal-title":"Cell Cycle"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"69","author":"Hashimoto M.","year":"2018","unstructured":"Hashimoto M.; Kamphorst A.O.; Im S.J.; Kissick H.T.; Pillai R.N.; Ramalingam S.S.; Araki K.; Ahmed R.; CD8 T cell exhaustion in chronic infection and cancer: Opportunities for interventions. Annu Rev Med  2018,69(1),301-318","journal-title":"Annu Rev Med"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00281-019-00744-5","volume":"41","author":"Kurachi M.","year":"2019","unstructured":"Kurachi M.; CD8 T cell exhaustion. Semin Immunopathol  2019,41(3),327-337","journal-title":"Semin Immunopathol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","volume":"18","author":"Rha M.S.","year":"2021","unstructured":"Rha M.S.; Shin E.C.; Activation or exhaustion of CD8 T cells in patients with COVID-19. Cell Mol Immunol  2021,18(10),2325-2333","journal-title":"Cell Mol Immunol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"622509","DOI":"10.3389\/fimmu.2020.622509","volume":"11","author":"Jiang W.","year":"2021","unstructured":"Jiang W.; He Y.; He W.; Wu G.; Zhou X.; Sheng Q.; Zhong W.; Lu Y.; Ding Y.; Lu Q.; Ye F.; Hua H.; Exhausted CD8 T cells in the tumor immune microenvironment: New pathways to therapy. Front Immunol  2021,11,622509","journal-title":"Front Immunol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imm.13588","volume":"168","author":"Huang Y.","year":"2023","unstructured":"Huang Y.; Jia A.; Wang Y.; Liu G.;  T cell exhaustion in anti-tumour immunity: The new insights for cancer immunotherapy. Immunology  2023,168(1),30-48","journal-title":"Immunology"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"14928","DOI":"10.1038\/s41598-020-71946-3","volume":"10","author":"Nojima I.","year":"2020","unstructured":"Nojima I.; Eikawa S.; Tomonobu N.; Hada Y.; Kajitani N.; Teshigawara S.; Miyamoto S.; Tone A.; Uchida H.A.; Nakatsuka A.; Eguchi J.; Shikata K.; Udono H.; Wada J.; Dysfunction of CD8 PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis. Sci Rep  2020,10(1),14928","journal-title":"Sci Rep"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/aid.2019.0078","volume":"36","author":"Shikuma C.M.","year":"2020","unstructured":"Shikuma C.M.; Chew G.M.; Kohorn L.; Souza S.A.; Chow D.; SahBandar I.N.; Park E.Y.; Hanks N.; Gangcuangco L.M.A.; Gerschenson M.; Ndhlovu L.C.; Short communication: Metformin reduces CD4 T cell exhaustion in HIV-infected adults on suppressive antiretroviral therapy. AIDS Res Hum Retroviruses  2020,36(4),303-305","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12079-021-00648-w","volume":"16","author":"Wu Z.","year":"2022","unstructured":"Wu Z.; Zhang C.; Najafi M.; Targeting of the tumor immune microenvironment by metformin. J Cell Commun Signal  2022,16(3),333-348","journal-title":"J Cell Commun Signal"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.4049\/jimmunol.1901213","volume":"204","author":"Zhang Z.","year":"2020","unstructured":"Zhang Z.; Li F.; Tian Y.; Cao L.; Gao Q.; Zhang C.; Zhang K.; Shen C.; Ping Y.; Maimela N.R.; Wang L.; Zhang B.; Zhang Y.; Metformin enhances the antitumor activity of CD8 T lymphocytes via the AMPK\u2013miR-107\u2013Eomes\u2013PD-1 pathway. J Immunol  2020,204(9),2575-2588","journal-title":"J Immunol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1158\/1538-7445.AM2017-5592","volume":"77","author":"Watanabe M.","year":"2017","unstructured":"Watanabe M.; Eikawa S.; Shien K.; Yamamoto H.; Shien T.; Soh J.; Doihara H.; Toyooka S.; Miyoshi S.; Udono H.; Abstract 5592: Metformin improves immune function of exhausted peripheral CD8 T cells derived from cancer patients. Cancer Res  2017,77(S13),5592-5592","journal-title":"Cancer Res"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000375435","volume":"38","author":"Xu X.D.","year":"2015","unstructured":"Xu X.D.; Shao S.X.; Jiang H.P.; Cao Y.W.; Wang Y.H.; Yang X.C.; Wang Y.L.; Wang X.S.; Niu H.T.; Warburg effect or reverse Warburg effect? A review of cancer metabolism. Oncol Res Treat  2015,38(3),117-122","journal-title":"Oncol Res Treat"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"Chang C.H.","year":"2015","unstructured":"Chang C.H.; Qiu J.; O\u2019Sullivan D.; Buck M.D.; Noguchi T.; Curtis J.D.; Chen Q.; Gindin M.; Gubin M.M.; van der Windt G.J.W.; Tonc E.; Schreiber R.D.; Pearce E.J.; Pearce E.L.; Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell  2015,162(6),1229-1241","journal-title":"Cell"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"113787","DOI":"10.1016\/j.bcp.2019.113787","volume":"174","author":"Bahrambeigi S.","year":"2020","unstructured":"Bahrambeigi S.; Shafiei-Irannejad V.; Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin. Biochem Pharmacol  2020,174,113787","journal-title":"Biochem Pharmacol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pharmthera.2012.10.003","volume":"137","author":"Zhang J.","year":"2013","unstructured":"Zhang J.; Liu J.; Tumor stroma as targets for cancer therapy. Pharmacol Ther  2013,137(2),200-215","journal-title":"Pharmacol Ther"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"e155148","DOI":"10.1172\/JCI155148","volume":"132","author":"Horn L.A.","year":"2022","unstructured":"Horn L.A.; Chariou P.L.; Gameiro S.R.; Qin H.; Iida M.; Fousek K.; Meyer T.J.; Cam M.; Flies D.; Langermann S.; Schlom J.; Palena C.; Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-\u03b2 signaling enables PD-L1\u2013mediated tumor eradication. J Clin Invest  2022,132(8),e155148","journal-title":"J Clin Invest"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fonc.2014.00062","volume":"4","author":"Augsten M.","year":"2014","unstructured":"Augsten M.; Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol  2014,4,62","journal-title":"Front Oncol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"668349","DOI":"10.3389\/fonc.2021.668349","volume":"11","author":"Gunaydin G.","year":"2021","unstructured":"Gunaydin G.; CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion. Front Oncol  2021,11,668349","journal-title":"Front Oncol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Jiang Y.","year":"2022","unstructured":"Jiang Y.; Zhang H.; Wang J.; Liu Y.; Luo T.; Hua H.; Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol  2022,15(1),34","journal-title":"J Hematol Oncol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"20009","DOI":"10.1073\/pnas.1013805107","volume":"107","author":"Kojima Y.","year":"2010","unstructured":"Kojima Y.; Acar A.; Eaton E.N.; Mellody K.T.; Scheel C.; Ben-Porath I.; Onder T.T.; Wang Z.C.; Richardson A.L.; Weinberg R.A.; Orimo A.; Autocrine TGF-\u03b2 and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci  2010,107(46),20009-20014","journal-title":"Proc Natl Acad Sci"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1158\/1535-7163.MCT-17-0927","volume":"17","author":"Xu S.","year":"2018","unstructured":"Xu S.; Yang Z.; Jin P.; Yang X.; Li X.; Wei X.; Wang Y.; Long S.; Zhang T.; Chen G.; Sun C.; Ma D.; Gao Q.; Metformin suppresses tumor progression by inactivating stromal fibroblasts in ovarian cancer. Mol Cancer Ther  2018,17(6),1291-1302","journal-title":"Mol Cancer Ther"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"10860","DOI":"10.1096\/fj.202000951RR","volume":"34","author":"Shao S.","year":"2020","unstructured":"Shao S.; Zhao L.; An G.; Zhang L.; Jing X.; Luo M.; Li W.; Meng D.; Ning Q.; Zhao X.; Lei J.; Metformin suppresses HIF-1\u03b1 expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer. FASEB J  2020,34(8),10860-10870","journal-title":"FASEB J"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"12044","DOI":"10.7150\/thno.47901","volume":"10","author":"Zhang X.","year":"2020","unstructured":"Zhang X.; Dong Y.; Zhao M.; Ding L.; Yang X.; Jing Y.; Song Y.; Chen S.; Hu Q.; Ni Y.; ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system. Theranostics  2020,10(26),12044-12059","journal-title":"Theranostics"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/lary.26489","volume":"127","author":"Curry J.","year":"2017","unstructured":"Curry J.; Johnson J.; Tassone P.; Vidal M.D.; Menezes D.W.; Sprandio J.; Mollaee M.; Cotzia P.; Birbe R.; Lin Z.; Gill K.; Duddy E.; Zhan T.; Leiby B.; Reyzer M.; Cognetti D.; Luginbuhl A.; Tuluc M.; Martinez-Outschoorn U.; Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial. Laryngoscope  2017,127(8),1808-1815","journal-title":"Laryngoscope"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"e1528815","DOI":"10.1080\/2162402X.2018.1528815","volume":"7","author":"Galluzzi L.","year":"2018","unstructured":"Galluzzi L.; Kroemer G.; Potent immunosuppressive effects of the oncometabolite R -2-hydroxyglutarate. OncoImmunology  2018,7(12),e1528815","journal-title":"OncoImmunology"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1089\/ars.2019.7902","volume":"33","author":"Je\u017eek P.","year":"2020","unstructured":"Je\u017eek P.; 2-Hydroxyglutarate in cancer cells. Antioxid Redox Signal  2020,33(13),903-926","journal-title":"Antioxid Redox Signal"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.1074\/jbc.REV119.007624","volume":"295","author":"Wang Y.P.","year":"2020","unstructured":"Wang Y.P.; Li J.T.; Qu J.; Yin M.; Lei Q.Y.; Metabolite sensing and signaling in cancer. J Biol Chem  2020,295(33),11938-11946","journal-title":"J Biol Chem"},{"key":"ref=169","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/metabo11080480","volume":"11","author":"Oh S.","year":"2021","unstructured":"Oh S.; Cho Y.; Chang M.; Park S.; Kwon H.; Metformin decreases 2-HG production through the MYC-PHGDH pathway in suppressing breast cancer cell proliferation. Metabolites  2021,11(8),480","journal-title":"Metabolites"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fonc.2018.00590","volume":"8","author":"Zhang X.","year":"2018","unstructured":"Zhang X.; Sch\u00f6nrogge M.; Eichberg J.; Wendt E.H.U.; Kumstel S.; Stenzel J.; Lindner T.; Jaster R.; Krause B.J.; Vollmar B.; Zechner D.; Blocking autophagy in cancer-associated fibroblasts supports chemotherapy of pancreatic cancer cells. Front Oncol  2018,8,590","journal-title":"Front Oncol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"106663","DOI":"10.1016\/j.intimp.2020.106663","volume":"85","author":"Ashrafizadeh M.","year":"2020","unstructured":"Ashrafizadeh M.; Farhood B.; Eleojo Musa A.; Taeb S.; Rezaeyan A.; Najafi M.; Abscopal effect in radioimmunotherapy. Int Immunopharmacol  2020,85,106663","journal-title":"Int Immunopharmacol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"172541","DOI":"10.1016\/j.ejphar.2019.172541","volume":"859","author":"Xue J.","year":"2019","unstructured":"Xue J.; Li L.; Li N.; Li F.; Qin X.; Li T.; Liu M.; Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1. Eur J Pharmacol  2019,859,172541","journal-title":"Eur J Pharmacol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","volume":"71","author":"Cha J.H.","year":"2018","unstructured":"Cha J.H.; Yang W.H.; Xia W.; Wei Y.; Chan L.C.; Lim S.O.; Li C.W.; Kim T.; Chang S.S.; Lee H.H.; Hsu J.L.; Wang H.L.; Kuo C.W.; Chang W.C.; Hadad S.; Purdie C.A.; McCoy A.M.; Cai S.; Tu Y.; Litton J.K.; Mittendorf E.A.; Moulder S.L.; Symmans W.F.; Thompson A.M.; Piwnica-Worms H.; Chen C.H.; Khoo K.H.; Hung M.C.; Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1. Mol Cell  2018,71(4),606-620.e7","journal-title":"Mol Cell"},{"key":"ref=174","first-page":"800","volume":"9","author":"Han Y.","year":"2019","unstructured":"Han Y.; Li C.W.; Hsu J.M.; Hsu J.L.; Chan L.C.; Tan X.; He G.J.; Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer. Am J Cancer Res  2019,9(4),800-815","journal-title":"Am J Cancer Res"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/1078-0432.CCR-12-2731","volume":"19","author":"Jiang X.","year":"2013","unstructured":"Jiang X.; Zhou J.; Giobbie-Hurder A.; Wargo J.; Hodi F.S.; The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition. Clin Cancer Res  2013,19(3),598-609","journal-title":"Clin Cancer Res"},{"key":"ref=176","first-page":"6965","volume":"11","author":"Zhang J.J.","year":"2019","unstructured":"Zhang J.J.; Zhang Q.S.; Li Z.Q.; Zhou J.W.; Du J.; Metformin attenuates PD-L1 expression through activating Hippo signaling pathway in colorectal cancer cells. Am J Transl Res  2019,11(11),6965-6976","journal-title":"Am J Transl Res"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"762523","DOI":"10.3389\/fonc.2021.762523","volume":"11","author":"Lu Y.","year":"2021","unstructured":"Lu Y.; Xin D.; Guan L.; Xu M.; Yang Y.; Chen Y.; Yang Y.; Wang-Gillam A.; Wang L.; Zong S.; Wang F.; Metformin downregulates PD-L1 expression in esophageal squamous cell carcinoma by inhibiting IL-6 signaling pathway. Front Oncol  2021,11,762523","journal-title":"Front Oncol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5983959","volume":"2022","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Hu J.; Sun Y.; Song B.; Zhang Y.; Lu Y.; Ma H.; Metformin synergizes with PD-L1 monoclonal antibody enhancing tumor immune response in treating non-small cell lung cancer and its molecular mechanism investigation. Evid Based Complement Alternat Med  2022,2022,1-9","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"12892","DOI":"10.3390\/ijms232112892","volume":"23","author":"Goggi J.L.","year":"2022","unstructured":"Goggi J.L.; Hartimath S.V.; Khanapur S.; Ramasamy B.; Chin Z.F.; Cheng P.; Chin H.X.; Hwang Y.Y.; Robins E.G.; Imaging memory T-cells stratifies response to adjuvant metformin combined with \u03b1PD-1 therapy. Int J Mol Sci  2022,23(21),12892","journal-title":"Int J Mol Sci"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00262-020-02703-8","volume":"70","author":"Kim Y.","year":"2021","unstructured":"Kim Y.; Vagia E.; Viveiros P.; Kang C.Y.; Lee J.Y.; Gim G.; Cho S.; Choi H.; Kim L.; Park I.; Choi J.; Chae Y.K.; Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC). Cancer Immunol Immunother  2021,70(4),961-965","journal-title":"Cancer Immunol Immunother"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.21873\/anticanres.15620","volume":"42","author":"Ciccarese C.","year":"2022","unstructured":"Ciccarese C.; Iacovelli R.; Buti S.; Primi F.; Astore S.; Massari F.; Ferrara M.G.; Palermo G.; Foschi N.; Iacovelli V.; Rossi E.; Schinzari G.; Bove P.; Bassi P.; Bria E.; Tortora G.; Concurrent nivolumab and metformin in diabetic cancer patients: Is it safe and more active? Anticancer Res  2022,42(3),1487-1493","journal-title":"Anticancer Res"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1158\/1538-7445.AM2022-3482","volume":"82","author":"Farran B.","year":"2022","unstructured":"Farran B.; Switchenko J.M.; Khalil L.; Shaib W.L.; Olson B.; Ruggieri A.; Wu C.; Alese O.B.; Diab M.; Lesinski G.B.; El-Rayes B.; Akce M.; Abstract 3482: Correlative analysis of metformin and nivolumab combination in treatment-refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Cancer Res  2022,82(S12),3482-3482","journal-title":"Cancer Res"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1634\/theoncologist.2019-0518","volume":"25","author":"Wang D.Y.","year":"2020","unstructured":"Wang D.Y.; McQuade J.L.; Rai R.R.; Park J.J.; Zhao S.; Ye F.; Beckermann K.E.; Rubinstein S.M.; Johnpulle R.; Long G.V.; Carlino M.S.; Menzies A.M.; Davies M.A.; Johnson D.B.; The impact of nonsteroidal anti-inflammatory drugs, beta blockers, and metformin on the efficacy of anti-PD-1 therapy in advanced melanoma. Oncologist  2020,25(3),e602-e605","journal-title":"Oncologist"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00280-018-03763-5","volume":"83","author":"Zhou H.","year":"2019","unstructured":"Zhou H.; Liu J.; Zhang Y.; Zhang L.; Inflammatory bowel disease associated with the combination treatment of nivolumab and metformin: Data from the FDA adverse event reporting system. Cancer Chemother Pharmacol  2019,83(3),599-601","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.7150\/thno.45777","volume":"11","author":"Cai S.","year":"2021","unstructured":"Cai S.; Chen Z.; Wang Y.; Wang M.; Wu J.; Tong Y.; Chen L.; Lu C.; Yang H.; Reducing PD-L1 expression with a self-assembled nanodrug: An alternative to PD-L1 antibody for enhanced chemo-immunotherapy. Theranostics  2021,11(4),1970-1981","journal-title":"Theranostics"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.molcel.2019.04.005","volume":"74","author":"Tu X.","year":"2019","unstructured":"Tu X.; Qin B.; Zhang Y.; Zhang C.; Kahila M.; Nowsheen S.; Yin P.; Yuan J.; Pei H.; Li H.; Yu J.; Song Z.; Zhou Q.; Zhao F.; Liu J.; Zhang C.; Dong H.; Mutter R.W.; Lou Z.; PD-L1 (B7-H1) competes with the rna exosome to regulate the DNA damage response and can be targeted to sensitize to radiation or chemotherapy. Mol Cell  2019,74(6),1215-1226.e4","journal-title":"Mol Cell"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ijbiomac.2022.10.167","volume":"224","author":"Zhou Z.","year":"2023","unstructured":"Zhou Z.; Liu Y.; Jiang X.; Zheng C.; Luo W.; Xiang X.; Qi X.; Shen J.; Metformin modified chitosan as a multi-functional adjuvant to enhance cisplatin-based tumor chemotherapy efficacy. Int J Biol Macromol  2023,224,797-809","journal-title":"Int J Biol Macromol"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","volume":"18","author":"Peng M.","year":"2019","unstructured":"Peng M.; Mo Y.; Wang Y.; Wu P.; Zhang Y.; Xiong F.; Guo C.; Wu X.; Li Y.; Li X.; Li G.; Xiong W.; Zeng Z.; Neoantigen vaccine: An emerging tumor immunotherapy. Mol Cancer  2019,18(1),128","journal-title":"Mol Cancer"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"e002614","DOI":"10.1136\/jitc-2021-002614","volume":"9","author":"Munoz L.E.","year":"2021","unstructured":"Munoz L.E.; Huang L.; Bommireddy R.; Sharma R.; Monterroza L.; Guin R.N.; Samaranayake S.G.; Pack C.D.; Ramachandiran S.; Reddy S.J.C.; Shanmugam M.; Selvaraj P.; Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy. J Immunother Cancer  2021,9(11),e002614","journal-title":"J Immunother Cancer"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10103-020-03061-8","volume":"36","author":"Kamanl\u0131 A.F.","year":"2021","unstructured":"Kamanl\u0131 A.F.; Y\u0131ld\u0131z M.Z.; \u00d6zyol E.; Deveci Ozkan A.; Sozen Kucukkara E.; Guney Eskiler G.; Investigation of LED-based photodynamic therapy efficiency on breast cancer cells. Lasers Med Sci  2021,36(3),563-569","journal-title":"Lasers Med Sci"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/php.13300","volume":"96","author":"Cramer G.M.","year":"2020","unstructured":"Cramer G.M.; Moon E.K.; Cengel K.A.; Busch T.M.; Photodynamic therapy and immune checkpoint blockade. Photochem Photobiol  2020,96(5),954-961","journal-title":"Photochem Photobiol"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"8026","DOI":"10.1021\/acsami.0c21743","volume":"13","author":"Xiong W.","year":"2021","unstructured":"Xiong W.; Qi L.; Jiang N.; Zhao Q.; Chen L.; Jiang X.; Li Y.; Zhou Z.; Shen J.; Metformin liposome-mediated PD-L1 downregulation for amplifying the photodynamic immunotherapy efficacy. ACS Appl Mater Interfaces  2021,13(7),8026-8041","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"100375","DOI":"10.1016\/j.mtbio.2022.100375","volume":"16","author":"Sun Y.","year":"2022","unstructured":"Sun Y.; Fang K.; Hu X.; Yang J.; Jiang Z.; Feng L.; Li R.; Rao Y.; Shi S.; Dong C.; NIR-light-controlled G-quadruplex hydrogel for synergistically enhancing photodynamic therapy via sustained delivery of metformin and catalase-like activity in breast cancer. Mater Today Bio  2022,16,100375","journal-title":"Mater Today Bio"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"106807","DOI":"10.1016\/j.intimp.2020.106807","volume":"87","author":"Ashrafizadeh M.","year":"2020","unstructured":"Ashrafizadeh M.; Farhood B.; Eleojo Musa A.; Taeb S.; Najafi M.; The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives. Int Immunopharmacol  2020,87,106807","journal-title":"Int Immunopharmacol"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1038\/s41598-022-11236-2","volume":"12","author":"Tojo M.","year":"2022","unstructured":"Tojo M.; Miyato H.; Koinuma K.; Horie H.; Tsukui H.; Kimura Y.; Kaneko Y.; Ohzawa H.; Yamaguchi H.; Yoshimura K.; Lefor A.K.; Sata N.; Kitayama J.; Metformin combined with local irradiation provokes abscopal effects in a murine rectal cancer model. Sci Rep  2022,12(1),7290","journal-title":"Sci Rep"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"e0249594","DOI":"10.1371\/journal.pone.0249594","volume":"16","author":"Zake D.M.","year":"2021","unstructured":"Zake D.M.; Kurlovics J.; Zaharenko L.; Komasilovs V.; Klovins J.; Stalidzans E.; Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues. PLoS One  2021,16(4),e0249594","journal-title":"PLoS One"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-008-0015-4","volume":"114","author":"Stambolic V.","year":"2009","unstructured":"Stambolic V.; Woodgett J.R.; Fantus I.G.; Pritchard K.I.; Goodwin P.J.; Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor? Breast Cancer Res Treat  2009,114(2),387-389","journal-title":"Breast Cancer Res Treat"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/JME-12-0007","volume":"48","author":"Dowling R.J.O.","year":"2012","unstructured":"Dowling R.J.O.; Niraula S.; Stambolic V.; Goodwin P.J.; Metformin in cancer: Translational challenges. J Mol Endocrinol  2012,48(3),R31-R43","journal-title":"J Mol Endocrinol"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature10927","volume":"483","author":"Liu L.","year":"2012","unstructured":"Liu L.; Ulbrich J.; M\u00fcller J.; W\u00fcstefeld T.; Aeberhard L.; Kress T.R.; Muthalagu N.; Rycak L.; Rudalska R.; Moll R.; Kempa S.; Zender L.; Eilers M.; Murphy D.J.; Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature  2012,483(7391),608-612","journal-title":"Nature"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-15-0068","volume":"13","author":"Zadra G.","year":"2015","unstructured":"Zadra G.; Batista J.L.; Loda M.; Dissecting the dual role of AMPK in Cancer: From experimental to human studies. Mol Cancer Res  2015,13(7),1059-1072","journal-title":"Mol Cancer Res"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1038\/emboj.2011.158","volume":"30","author":"Massie C.E.","year":"2011","unstructured":"Massie C.E.; Lynch A.; Ramos-Montoya A.; Boren J.; Stark R.; Fazli L.; Warren A.; Scott H.; Madhu B.; Sharma N.; Bon H.; Zecchini V.; Smith D.M.; DeNicola G.M.; Mathews N.; Osborne M.; Hadfield J.; MacArthur S.; Adryan B.; Lyons S.K.; Brindle K.M.; Griffiths J.; Gleave M.E.; Rennie P.S.; Neal D.E.; Mills I.G.; The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J  2011,30(13),2719-2733","journal-title":"EMBO J"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.18632\/oncotarget.3629","volume":"6","author":"Li W.","year":"2015","unstructured":"Li W.; Saud S.M.; Young M.R.; Chen G.; Hua B.; Targeting AMPK for cancer prevention and treatment. Oncotarget  2015,6(10),7365-7378","journal-title":"Oncotarget"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230703143907","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/218382\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230703143907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T06:28:37Z","timestamp":1727936917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/218382\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":202,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230703143907","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}